Outcome of Budd-Chiari Syndrome Patients Treated With Direct Oral Anticoagulants: An Austrian Multicenter Study.

Georg Semmler; Alexander Lindorfer; Benedikt Schäfer; Stefan Bartl; Stephanie Hametner-Schreil; Sophie Gensluckner; Lorenz Balcar; Katharina Pomej; Katharina Lampichler; Michael Trauner; Elmar Aigner; Christian Datz; Heinz Zoller; Harald Hofer; Rainer Schöfl; Mattias Mandorfer; Thomas Reiberger; Bernhard Scheiner

doi:10.1016/j.cgh.2022.04.024

Outcome of Budd-Chiari Syndrome Patients Treated With Direct Oral Anticoagulants: An Austrian Multicenter Study.

Georg Semmler
, Alexander Lindorfer
, Benedikt Schäfer
, Stefan Bartl
, Stephanie Hametner-Schreil
, Sophie Gensluckner
, Lorenz Balcar
, Katharina Pomej
, Katharina Lampichler
, Michael Trauner
, Elmar Aigner (Co-author)
, Christian Datz (Co-author)
, Heinz Zoller
, Harald Hofer
, Rainer Schöfl
, Mattias Mandorfer
, Thomas Reiberger
, Bernhard Scheiner

Research output: Contribution to journal › Original Article › peer-review

28 Citations (Web of Science)

Original language	English
Pages (from-to)	978-987.e2
Journal	CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
Volume	21
Issue number	4
DOIs	https://doi.org/10.1016/j.cgh.2022.04.024
Publication status	Published - Apr 2023

Keywords

INTRAHEPATIC PORTOSYSTEMIC SHUNT
SPLANCHNIC VEIN-THROMBOSIS
HEPATOCELLULAR-CARCINOMA
PLACEMENT
SURVIVAL
Severity of Illness Index
End Stage Liver Disease/drug therapy
Administration, Oral
Humans
Dabigatran/adverse effects
Anticoagulants/adverse effects
Budd-Chiari Syndrome/drug therapy
Carcinoma, Hepatocellular/drug therapy
Austria
Liver Neoplasms/drug therapy
Gastrointestinal Hemorrhage/chemically induced
Atrial Fibrillation/drug therapy
Retrospective Studies
Vitamin K

Access to Document

10.1016/j.cgh.2022.04.024

Cite this

Semmler, G., Lindorfer, A., Schäfer, B., Bartl, S., Hametner-Schreil, S., Gensluckner, S., Balcar, L., Pomej, K., Lampichler, K., Trauner, M., Aigner, E., Datz, C., Zoller, H., Hofer, H., Schöfl, R., Mandorfer, M., Reiberger, T., & Scheiner, B. (2023). Outcome of Budd-Chiari Syndrome Patients Treated With Direct Oral Anticoagulants: An Austrian Multicenter Study. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 21(4), 978-987.e2. https://doi.org/10.1016/j.cgh.2022.04.024

@article{028892748a40483ea414a7a12648d5f1,

title = "Outcome of Budd-Chiari Syndrome Patients Treated With Direct Oral Anticoagulants: An Austrian Multicenter Study.",

keywords = "INTRAHEPATIC PORTOSYSTEMIC SHUNT, SPLANCHNIC VEIN-THROMBOSIS, HEPATOCELLULAR-CARCINOMA, PLACEMENT, SURVIVAL, Severity of Illness Index, End Stage Liver Disease/drug therapy, Administration, Oral, Humans, Dabigatran/adverse effects, Anticoagulants/adverse effects, Budd-Chiari Syndrome/drug therapy, Carcinoma, Hepatocellular/drug therapy, Austria, Liver Neoplasms/drug therapy, Gastrointestinal Hemorrhage/chemically induced, Atrial Fibrillation/drug therapy, Retrospective Studies, Vitamin K",

author = "Georg Semmler and Alexander Lindorfer and Benedikt Sch{\"a}fer and Stefan Bartl and Stephanie Hametner-Schreil and Sophie Gensluckner and Lorenz Balcar and Katharina Pomej and Katharina Lampichler and Michael Trauner and Elmar Aigner and Christian Datz and Heinz Zoller and Harald Hofer and Rainer Sch{\"o}fl and Mattias Mandorfer and Thomas Reiberger and Bernhard Scheiner",

note = "Lehr-KH Oberndorf: Datz: Department of Internal Medicine, General Hospital Oberndorf, Teaching Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria; Gensluckner, Aigner: Department of Medicine I, Paracelsus Medical University Salzburg, Salzburg, Austria ",

year = "2023",

month = apr,

doi = "10.1016/j.cgh.2022.04.024",

language = "English",

volume = "21",

pages = "978--987.e2",

journal = "CLINICAL GASTROENTEROLOGY AND HEPATOLOGY",

issn = "1542-3565",

publisher = "Elsevier ",

number = "4",

}

Semmler, G, Lindorfer, A, Schäfer, B, Bartl, S, Hametner-Schreil, S, Gensluckner, S, Balcar, L, Pomej, K, Lampichler, K, Trauner, M, Aigner, E , Datz, C, Zoller, H, Hofer, H, Schöfl, R, Mandorfer, M, Reiberger, T & Scheiner, B 2023, 'Outcome of Budd-Chiari Syndrome Patients Treated With Direct Oral Anticoagulants: An Austrian Multicenter Study.', CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, vol. 21, no. 4, pp. 978-987.e2. https://doi.org/10.1016/j.cgh.2022.04.024

TY - JOUR

T1 - Outcome of Budd-Chiari Syndrome Patients Treated With Direct Oral Anticoagulants: An Austrian Multicenter Study.

AU - Semmler, Georg

AU - Lindorfer, Alexander

AU - Schäfer, Benedikt

AU - Bartl, Stefan

AU - Hametner-Schreil, Stephanie

AU - Gensluckner, Sophie

AU - Balcar, Lorenz

AU - Pomej, Katharina

AU - Lampichler, Katharina

AU - Trauner, Michael

AU - Aigner, Elmar

AU - Datz, Christian

AU - Zoller, Heinz

AU - Hofer, Harald

AU - Schöfl, Rainer

AU - Mandorfer, Mattias

AU - Reiberger, Thomas

AU - Scheiner, Bernhard

N1 - Lehr-KH Oberndorf: Datz: Department of Internal Medicine, General Hospital Oberndorf, Teaching Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria; Gensluckner, Aigner: Department of Medicine I, Paracelsus Medical University Salzburg, Salzburg, Austria

PY - 2023/4

Y1 - 2023/4

KW - INTRAHEPATIC PORTOSYSTEMIC SHUNT

KW - SPLANCHNIC VEIN-THROMBOSIS

KW - HEPATOCELLULAR-CARCINOMA

KW - PLACEMENT

KW - SURVIVAL

KW - Severity of Illness Index

KW - End Stage Liver Disease/drug therapy

KW - Administration, Oral

KW - Humans

KW - Dabigatran/adverse effects

KW - Anticoagulants/adverse effects

KW - Budd-Chiari Syndrome/drug therapy

KW - Carcinoma, Hepatocellular/drug therapy

KW - Austria

KW - Liver Neoplasms/drug therapy

KW - Gastrointestinal Hemorrhage/chemically induced

KW - Atrial Fibrillation/drug therapy

KW - Retrospective Studies

KW - Vitamin K

U2 - 10.1016/j.cgh.2022.04.024

DO - 10.1016/j.cgh.2022.04.024

M3 - Original Article

C2 - 35533994

SN - 1542-3565

VL - 21

SP - 978-987.e2

JO - CLINICAL GASTROENTEROLOGY AND HEPATOLOGY

JF - CLINICAL GASTROENTEROLOGY AND HEPATOLOGY

IS - 4

ER -